TY - JOUR
T1 - A genome-wide association study identifies two new susceptibility loci for lung adenocarcinoma in the Japanese population
AU - Shiraishi, Kouya
AU - Kunitoh, Hideo
AU - Daigo, Yataro
AU - Takahashi, Atsushi
AU - Goto, Koichi
AU - Sakamoto, Hiromi
AU - Ohnami, Sumiko
AU - Shimada, Yoko
AU - Ashikawa, Kyota
AU - Saito, Akira
AU - Watanabe, Shun Ichi
AU - Tsuta, Koji
AU - Kamatani, Naoyuki
AU - Yoshida, Teruhiko
AU - Nakamura, Yusuke
AU - Yokota, Jun
AU - Kubo, Michiaki
AU - Kohno, Takashi
N1 - Funding Information:
We thank all of the subjects for participating in the study, and we also thank the collaborating physicians for assisting with sample collection. We are grateful to the members of BioBank Japan, the National Cancer Center Biobank and the Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan for supporting our study. We thank Y. Aoi, T. Odaka, M. Okuyama, H. Totsuka, S. Chiku, A. Kuchiba and the technical staff of the Center for Genome Medicine, National Cancer Center Research Institute, for providing technical and methodological assistance. We also thank H. Hirose of Health Center, Keio University and D. Saito of National Cancer Center Hospital (present affiliation: Nihonbashi Daizo Clinic) for DNA samples of control subjects. This work was supported in part by Grants-in-Aid from the Ministry of Health, Labor and Welfare for Research on Applying Health Technology and for the 3rd-term Comprehensive 10-year Strategy for Cancer Control; from the Ministry of Education, Culture, Sports, Science and Technology of Japan for Scientific Research on Innovative Areas (22131006); from the Japan Society for the Promotion of Science for Research Activity Start-up (23800073) and for Young Scientists (B) (24790340); and by the National Cancer Center Research and Development Fund. This work was also conducted as a part of the BioBank Japan Project supported by the Ministry of Education, Culture, Sports, Science and Technology, Japan. The National Cancer Center Biobank is supported by the National Cancer Center Research and Development Fund, Japan.
PY - 2012/8
Y1 - 2012/8
N2 - Lung adenocarcinoma is the most common histological type of lung cancer, and its incidence is increasing worldwide. To identify genetic factors influencing risk of lung adenocarcinoma, we conducted a genome-wide association study and two validation studies in the Japanese population comprising a total of 6,029 individuals with lung adenocarcinoma (cases) and 13,535 controls. We confirmed two previously reported risk loci, 5p15.33 (rs2853677, P combined = 2.8 × 10 -40, odds ratio (OR) = 1.41) and 3q28 (rs10937405, P combined = 6.9 × 10 -17, OR = 1.25), and identified two new susceptibility loci, 17q24.3 (rs7216064, P combined = 7.4 × 10 -11, OR = 1.20) and 6p21.3 (rs3817963, P combined = 2.7 × 10 -10, OR = 1.18). These data provide further evidence supporting a role for genetic susceptibility in the development of lung adenocarcinoma.
AB - Lung adenocarcinoma is the most common histological type of lung cancer, and its incidence is increasing worldwide. To identify genetic factors influencing risk of lung adenocarcinoma, we conducted a genome-wide association study and two validation studies in the Japanese population comprising a total of 6,029 individuals with lung adenocarcinoma (cases) and 13,535 controls. We confirmed two previously reported risk loci, 5p15.33 (rs2853677, P combined = 2.8 × 10 -40, odds ratio (OR) = 1.41) and 3q28 (rs10937405, P combined = 6.9 × 10 -17, OR = 1.25), and identified two new susceptibility loci, 17q24.3 (rs7216064, P combined = 7.4 × 10 -11, OR = 1.20) and 6p21.3 (rs3817963, P combined = 2.7 × 10 -10, OR = 1.18). These data provide further evidence supporting a role for genetic susceptibility in the development of lung adenocarcinoma.
UR - http://www.scopus.com/inward/record.url?scp=84864416630&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84864416630&partnerID=8YFLogxK
U2 - 10.1038/ng.2353
DO - 10.1038/ng.2353
M3 - Article
C2 - 22797724
AN - SCOPUS:84864416630
SN - 1061-4036
VL - 44
SP - 900
EP - 903
JO - Nature Genetics
JF - Nature Genetics
IS - 8
ER -
